These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 30905477)

  • 1. Methamphetamine psychosis: Lack of association with stimulant prescription ADHD medications.
    Mann DM; Marco CA; Detherage JP; Greene PJ; Ross DE
    Am J Emerg Med; 2019 Sep; 37(9):1802-1803. PubMed ID: 30905477
    [No Abstract]   [Full Text] [Related]  

  • 2. Cocaine or Methamphetamine Use During Young Adulthood Following Stimulant Use for Attention-Deficit/Hyperactivity Disorder During Adolescence.
    McCabe SE; Schulenberg JE; Wilens TE; Schepis TS; McCabe VV; Veliz PT
    JAMA Netw Open; 2023 Jul; 6(7):e2322650. PubMed ID: 37432689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physician practices to prevent ADHD stimulant diversion and misuse.
    Colaneri N; Keim S; Adesman A
    J Subst Abuse Treat; 2017 Mar; 74():26-34. PubMed ID: 28132697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is age of onset and duration of stimulant therapy for ADHD associated with cocaine, methamphetamine, and prescription stimulant misuse?
    McCabe SE; Figueroa O; McCabe VV; Schepis TS; Schulenberg JE; Veliz PT; Werner KS; Wilens TE
    J Child Psychol Psychiatry; 2024 Jan; 65(1):100-111. PubMed ID: 37062713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knowledge, Attitudes, and Practice Patterns of Health Professionals Toward Medical and Non-medical Stimulant Use by Young Adults.
    Loskutova NY; Waterman J; Callen E; Staton EW; Bullard E; Shields J
    J Am Board Fam Med; 2020; 33(1):59-70. PubMed ID: 31907247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacotherapy for incident attention-deficit/hyperactivity disorder: practice patterns and quality metrics.
    Bussing R; Narwaney KJ; Winterstein AG; Newton DA; DeBar L; Boscarino JA; Toh S; Pawloski P; Nordin JD; Herrinton LJ; Mason D; Daley MF
    Curr Med Res Opin; 2014 Aug; 30(8):1687-99. PubMed ID: 24635013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shopping behavior for ADHD drugs: results of a cohort study in a pharmacy database.
    Cepeda MS; Fife D; Berwaerts J; Yuan Y; Mastrogiovanni G
    Drugs R D; 2014 Sep; 14(3):205-11. PubMed ID: 25118848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. National Patterns of Commonly Prescribed Psychotropic Medications to Young People.
    Sultan RS; Correll CU; Schoenbaum M; King M; Walkup JT; Olfson M
    J Child Adolesc Psychopharmacol; 2018 Apr; 28(3):158-165. PubMed ID: 29376743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychotherapeutic medication patterns for youths with attention-deficit/hyperactivity disorder.
    Zito JM; Safer DJ; dosReis S; Magder LS; Gardner JF; Zarin DA
    Arch Pediatr Adolesc Med; 1999 Dec; 153(12):1257-63. PubMed ID: 10591302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First psychotic episode risk markers for primary psychosis amongst people who use methamphetamine.
    McKetin R; Hides L; Kavanagh DJ; Saunders JB; Dawe S
    Schizophr Res; 2018 Sep; 199():456-457. PubMed ID: 29680188
    [No Abstract]   [Full Text] [Related]  

  • 11. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association.
    Goldman LS; Genel M; Bezman RJ; Slanetz PJ
    JAMA; 1998 Apr; 279(14):1100-7. PubMed ID: 9546570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Care Provision and Prescribing Practices of Physicians Treating Children and Adolescents With ADHD.
    Patel A; Medhekar R; Ochoa-Perez M; Aparasu RR; Chan W; Sherer JT; Alonzo J; Chen H
    Psychiatr Serv; 2017 Jul; 68(7):681-688. PubMed ID: 28196459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indication and use of drug products used to treat attention-deficit/hyperactivity disorder: a cross-sectional study with inference on the likelihood of treatment in adulthood.
    Brinker A; Mosholder A; Schech SD; Burgess M; Avigan M
    J Child Adolesc Psychopharmacol; 2007 Jun; 17(3):328-33. PubMed ID: 17630866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overlapping Prescriptions of Stimulants for Children and Adolescents With Attention-Deficit Hyperactivity Disorder.
    Chen CY; Yeh HH; Fang SY; Wu EC; Chang IS; Lin KM
    Psychiatr Serv; 2012 Oct; 63(10):1011-8. PubMed ID: 22911441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in the prescribing of stimulant medication for the treatment of attention deficit hyperactivity disorder in children and adolescents in New South Wales.
    Salmelainen P
    N S W Public Health Bull; 2002 Jan; 13 Suppl 1():1-65. PubMed ID: 12189396
    [No Abstract]   [Full Text] [Related]  

  • 16. Predictors of methamphetamine psychosis: history of ADHD-relevant childhood behaviors and drug exposure.
    Salo R; Fassbender C; Iosif AM; Ursu S; Leamon MH; Carter C
    Psychiatry Res; 2013 Dec; 210(2):529-35. PubMed ID: 23896355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of crystalline methamphetamine ("ice") users and other patients with toxicology-related problems presenting to a hospital emergency department.
    Dargan PI; Wood DM
    Med J Aust; 2008 Aug; 189(4):234. PubMed ID: 18707575
    [No Abstract]   [Full Text] [Related]  

  • 18. Physician Office Visits for Attention-deficit/Hyperactivity Disorder in Children and Adolescents Aged 4-17 Years: United States, 2012-2013.
    Albert M; Rui P; Ashman JJ
    NCHS Data Brief; 2017 Jan; (269):1-8. PubMed ID: 28135186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risks of psychosis in methamphetamine users: cross-sectional study in Thailand.
    Lamyai W; Pono K; Indrakamhaeng D; Saengsin A; Songhong N; Khuwuthyakorn P; Sribanditmongkol P; Junkuy A; Srisurapanont M
    BMJ Open; 2019 Oct; 9(10):e032711. PubMed ID: 31615802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Common Use of Stimulants and Alpha-2 Agonists to Treat Preschool Attention-Deficit Hyperactivity Disorder: A DBPNet Study.
    Blum NJ; Shults J; Harstad E; Wiley S; Augustyn M; Meinzen-Derr JK; Wolraich ML; Barbaresi WJ
    J Dev Behav Pediatr; 2018 Sep; 39(7):531-537. PubMed ID: 29851669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.